Nephropathy
Not recruitingStudy on the Effects of Povetacicept for Adults with IgA Nephropathy
- Disease:Nephropathy
- Substances:Povetacicept
Belgium- Participants:18–64 years · 65+ years
- Substances:Povetacicept
- Sponsor:Alpine Immune Sciences Inc.
Rare diseases
Investigational molecules
Locations
Back to Belgium1 129 clinical trials in Leuven, Belgium across 3 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
BelgiumThe busiest research cities in the country
What the registry says about research in the country
Clinical investigations focusing on ulcerative colitis and innovative treatments for inflammatory bowel conditions. Studies include evaluation of novel therapies for short bowel syndrome and gastrointestinal motility disorders.
Current trials are examining drug absorption and therapeutic responses in patients with various digestive conditions.
Groundbreaking research in head and neck cancer treatments, including innovative radiotherapy approaches. Studies are also investigating new therapies for bladder cancer, focusing on early-stage interventions.
Emphasis on combining traditional treatments with novel therapeutic approaches to improve patient outcomes.
Comprehensive studies on Alzheimer's disease and frontotemporal dementia, investigating disease progression and potential treatments. Research includes innovative approaches to understanding brain circuit functionality.
Advanced imaging techniques are being utilized to track disease progression and treatment effectiveness.
Tell us about your condition – we search every trial in Europe and connect you with the right site.